Resalis Therapeutics
PrivateLast Round
Strategic
Oct 28, 2024
Total Funding Raised
$21.71M
Momentum Score
50 /100
Company Overview
Resalis Therapeutics is a biotechnology company developing non-coding RNA-based therapies for metabolic disorders such as obesity and fatty liver disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resalis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Resalis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 28, 2024 | ||||
| Series A | Jan 4, 2024 | ||||
| Seed | Feb 22, 2023 |
Key People
Founding team and executive leadership
Resalis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Club degli Investitori | Seed, Series A |
| Claris Ventures | Series A, Seed |
| Sunstone Life Science Ventures | Series A |
| Italian Angels for Growth | Seed |
Resalis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Resalis Therapeutics's valuation, stock price, and market status.
